Beck R - Search Results

1

Preclinical Comparison of the ⁶⁴Cu- and ⁶⁸Ga-Labeled GRPR-Targeted Compounds RM2 and AMTG, as Well as First-in-Humans [⁶⁸Ga]Ga-AMTG PET/CT.

Koller L, Joksch M, Schwarzenböck S, Kurth J, Heuschkel M, Holzleitner N, Beck R, von Amsberg G, Wester HJ, Krause BJ, Günther T. Koller L, et al. Among authors: beck r. J Nucl Med. 2023 Oct;64(10):1654-1659. doi: 10.2967/jnumed.123.265771. Epub 2023 Jul 20. J Nucl Med. 2023. PMID: 37934025

2

Hypoxia-specific tumor imaging with 18F-fluoroazomycin arabinoside.

Piert M, Machulla HJ, Picchio M, Reischl G, Ziegler S, Kumar P, Wester HJ, Beck R, McEwan AJ, Wiebe LI, Schwaiger M. Piert M, et al. Among authors: beck r. J Nucl Med. 2005 Jan;46(1):106-13. J Nucl Med. 2005. PMID: 15632040 Free article.

3

PET and PET/CT studies of tumor tissue oxygenation.

Krause BJ, Beck R, Souvatzoglou M, Piert M. Krause BJ, et al. Among authors: beck r. Q J Nucl Med Mol Imaging. 2006 Mar;50(1):28-43. Q J Nucl Med Mol Imaging. 2006. PMID: 16557202 Free article. Review.

4

Tumour hypoxia imaging with [18F]FAZA PET in head and neck cancer patients: a pilot study.

Souvatzoglou M, Grosu AL, Röper B, Krause BJ, Beck R, Reischl G, Picchio M, Machulla HJ, Wester HJ, Piert M. Souvatzoglou M, et al. Among authors: beck r. Eur J Nucl Med Mol Imaging. 2007 Oct;34(10):1566-75. doi: 10.1007/s00259-007-0424-3. Epub 2007 Apr 20. Eur J Nucl Med Mol Imaging. 2007. PMID: 17447061

5

Intratumoral spatial distribution of hypoxia and angiogenesis assessed by 18F-FAZA and 125I-Gluco-RGD autoradiography.

Picchio M, Beck R, Haubner R, Seidl S, Machulla HJ, Johnson TD, Wester HJ, Reischl G, Schwaiger M, Piert M. Picchio M, et al. Among authors: beck r. J Nucl Med. 2008 Apr;49(4):597-605. doi: 10.2967/jnumed.107.046870. Epub 2008 Mar 14. J Nucl Med. 2008. PMID: 18344437 Free article.

6

Therapeutic Radiopharmaceuticals Targeting Integrin αvβ6.

Färber SF, Wurzer A, Reichart F, Beck R, Kessler H, Wester HJ, Notni J. Färber SF, et al. Among authors: beck r. ACS Omega. 2018 Feb 28;3(2):2428-2436. doi: 10.1021/acsomega.8b00035. ACS Omega. 2018. PMID: 30023833 Free PMC article.

7

Effect of Carbohydration on the Theranostic Tracer PSMA I&T.

Schmidt A, Wirtz M, Färber SF, Osl T, Beck R, Schottelius M, Schwaiger M, Wester HJ. Schmidt A, et al. Among authors: beck r. ACS Omega. 2018 Jul 31;3(7):8278-8287. doi: 10.1021/acsomega.8b00790. Epub 2018 Jul 25. ACS Omega. 2018. PMID: 30087939 Free PMC article.

8

Synthesis and Preclinical Characterization of the PSMA-Targeted Hybrid Tracer PSMA-I&F for Nuclear and Fluorescence Imaging of Prostate Cancer.

Schottelius M, Wurzer A, Wissmiller K, Beck R, Koch M, Gorpas D, Notni J, Buckle T, van Oosterom MN, Steiger K, Ntziachristos V, Schwaiger M, van Leeuwen FWB, Wester HJ. Schottelius M, et al. Among authors: beck r. J Nucl Med. 2019 Jan;60(1):71-78. doi: 10.2967/jnumed.118.212720. Epub 2018 Sep 20. J Nucl Med. 2019. PMID: 30237214 Free PMC article.

9

Radiohybrid Ligands: A Novel Tracer Concept Exemplified by ¹⁸F- or ⁶⁸Ga-Labeled rhPSMA Inhibitors.

Wurzer A, Di Carlo D, Schmidt A, Beck R, Eiber M, Schwaiger M, Wester HJ. Wurzer A, et al. Among authors: beck r. J Nucl Med. 2020 May;61(5):735-742. doi: 10.2967/jnumed.119.234922. Epub 2019 Dec 20. J Nucl Med. 2020. PMID: 31862804 Free PMC article.

10

Preclinical comparison of four [¹⁸F, ^natGa]rhPSMA-7 isomers: influence of the stereoconfiguration on pharmacokinetics.

Wurzer A, Parzinger M, Konrad M, Beck R, Günther T, Felber V, Färber S, Di Carlo D, Wester HJ. Wurzer A, et al. Among authors: beck r. EJNMMI Res. 2020 Dec 7;10(1):149. doi: 10.1186/s13550-020-00740-z. EJNMMI Res. 2020. PMID: 33284394 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,852 results

Search Page